171 related articles for article (PubMed ID: 1164612)
1. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
Ellis FR; Clarke IM; Modgill M; Currie S; Harriman DG
Br Med J; 1975 Aug; 3(5982):511-3. PubMed ID: 1164612
[TBL] [Abstract][Full Text] [Related]
2. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.
Britt BA; Endrenyi L; Peters PL; Kwong FH; Kadijevic L
Can Anaesth Soc J; 1976 May; 23(3):263-84. PubMed ID: 938964
[TBL] [Abstract][Full Text] [Related]
3. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia.
Isherwood DM; Ridley J; Wilson J
Br J Obstet Gynaecol; 1975 Apr; 82(4):346-9. PubMed ID: 1125158
[TBL] [Abstract][Full Text] [Related]
4. Identification of susceptibility to malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
[TBL] [Abstract][Full Text] [Related]
5. Masseter muscle rigidity and malignant hyperthermia susceptibility.
Rosenberg H; Fletcher JE
Anesth Analg; 1986 Feb; 65(2):161-4. PubMed ID: 3942303
[TBL] [Abstract][Full Text] [Related]
6. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
Br J Anaesth; 1984 Nov; 56(11):1267-9. PubMed ID: 6487446
[TBL] [Abstract][Full Text] [Related]
7. Screening for malignant hyperpyrexia.
Ellis FR; Keaney NP; Harriman DG; Sumner DW; Kyei-Mensah K; Tyrrell JH; Hargreaves JB; Parikh RK; Mulrooney PL
Br Med J; 1972 Sep; 3(5826):559-61. PubMed ID: 5069639
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperpyrexia.
Ellis FR
Anaesthesia; 1973 May; 28(3):245-52. PubMed ID: 4713948
[No Abstract] [Full Text] [Related]
9. Diagnostic value of serum creatine phosphokinase activity for the porcine malignant hyperthermia syndrome.
Heffron JJ; Mitchell G
Anesth Analg; 1975; 54(4):536-9. PubMed ID: 1170791
[TBL] [Abstract][Full Text] [Related]
10. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
Meltzer HY; Hassan SZ; Russo P; Cho HW
Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694
[TBL] [Abstract][Full Text] [Related]
11. Biochemical basis of malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
[TBL] [Abstract][Full Text] [Related]
12. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
Flewellen EH; Nelson TE
Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
[No Abstract] [Full Text] [Related]
13. [Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl)].
Morikawa S; Murata M; Murata H; Iwai S
Masui; 1979 Feb; 28(2):187-96. PubMed ID: 423358
[No Abstract] [Full Text] [Related]
14. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
[TBL] [Abstract][Full Text] [Related]
15. Screening for malignant hyperpyrexia.
Nelson TE; Austin KL; Denborough MA
Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
[TBL] [Abstract][Full Text] [Related]
16. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
Paasuke RT; Brownell AK
JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of creatinine phosphokinase screening as a predictor of malignant hyperthermia. A prospective study.
Amaranath L; Lavin TJ; Trusso RA; Boutros AR
Br J Anaesth; 1983 Jun; 55(6):531-3. PubMed ID: 6860521
[TBL] [Abstract][Full Text] [Related]
19. Letter: Serum creatine phosphokinase and malignant hyperpyrexia.
Ryan DW; Appleyard TN
Br Med J; 1976 Jan; 1(6001):96. PubMed ID: 1244960
[No Abstract] [Full Text] [Related]
20. Malignant hyperpyrexia.
Denborough MA
Compr Ther; 1975 Dec; 1(8):51-6. PubMed ID: 770064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
